287 related articles for article (PubMed ID: 16311006)
1. [Intrathecal use of colistin].
Charra B; Hachimi A; Benslama A; Motaouakkil S
Ann Fr Anesth Reanim; 2006 Feb; 25(2):215. PubMed ID: 16311006
[No Abstract] [Full Text] [Related]
2. [Intrathecal use of amikacin and colistin].
Hachimi A; Charra B; Benslama A; Motaouakkil S
Ann Fr Anesth Reanim; 2008 Jan; 27(1):113-4. PubMed ID: 18077128
[No Abstract] [Full Text] [Related]
3. Post-surgical meningitis due to multiresistant Acinetobacter baumannii. Effective treatment with intravenous and/or intraventricular colistin and therapeutic dilemmas.
Paramythiotou E; Karakitsos D; Aggelopoulou H; Sioutos P; Samonis G; Karabinis A
Med Mal Infect; 2007 Feb; 37(2):124-5. PubMed ID: 17270377
[TBL] [Abstract][Full Text] [Related]
4. Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin.
Bukhary Z; Mahmood W; Al-Khani A; Al-Abdely HM
Saudi Med J; 2005 Apr; 26(4):656-8. PubMed ID: 15900379
[TBL] [Abstract][Full Text] [Related]
5. [Nosocomial pneumonia caused by multiresistant Acinetobacter baumanii treated by colistin and rifampicin].
Motaouakkil S; Charra B; Hachimi A; Benslama A
Ann Fr Anesth Reanim; 2006 May; 25(5):543-4. PubMed ID: 16488103
[No Abstract] [Full Text] [Related]
6. Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin.
Ho YH; Wang LS; Chao HJ; Chang KC; Su CF
J Microbiol Immunol Infect; 2007 Dec; 40(6):537-40. PubMed ID: 18087636
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin.
Katragkou A; Roilides E
J Clin Microbiol; 2005 Sep; 43(9):4916-7. PubMed ID: 16145177
[No Abstract] [Full Text] [Related]
8. Successful treatment of Acinetobacter meningitis with intrathecal polymyxin E.
Benifla M; Zucker G; Cohen A; Alkan M
J Antimicrob Chemother; 2004 Jul; 54(1):290-2. PubMed ID: 15190037
[No Abstract] [Full Text] [Related]
9. Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin.
Rodriguez CH; Bombicino K; Granados G; Nastro M; Vay C; Famiglietti A
Diagn Microbiol Infect Dis; 2009 Oct; 65(2):188-91. PubMed ID: 19748431
[TBL] [Abstract][Full Text] [Related]
10. [Intraventricular colistin use in neonatal meningitis caused by Acinetobacter baumanii].
Alaoui SY; Nejmi SE; Chakir AA; Hmamouchi B; Chlilek A
Ann Fr Anesth Reanim; 2011 Nov; 30(11):854-5. PubMed ID: 21981848
[No Abstract] [Full Text] [Related]
11. Amikacin and colistin for treatment of Acinetobacter baumannii meningitis.
Fulnecky EJ; Wright D; Scheld WM; Kanawati L; Shoham S
J Infect; 2005 Dec; 51(5):e249-51. PubMed ID: 15913780
[TBL] [Abstract][Full Text] [Related]
12. [The efficacy of the tigecycline-colistin association in the treatment of multi-resistant Acinetobacter baumannii meningitis].
Regaieg K; Bahloul M; Turki O; Mnif B; Bouaziz M
Med Mal Infect; 2017 Mar; 47(2):175-177. PubMed ID: 28215823
[No Abstract] [Full Text] [Related]
13. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii.
Motaouakkil S; Charra B; Hachimi A; Nejmi H; Benslama A; Elmdaghri N; Belabbes H; Benbachir M
J Infect; 2006 Oct; 53(4):274-8. PubMed ID: 16442632
[TBL] [Abstract][Full Text] [Related]
14. Post-neurosurgical meningitis due to multidrug-resistant Acinetobacter baumanii treated with intrathecal colistin: case report and review of the literature.
Al Shirawi N; Memish ZA; Cherfan A; Al Shimemeri A
J Chemother; 2006 Oct; 18(5):554-8. PubMed ID: 17127235
[TBL] [Abstract][Full Text] [Related]
15. [Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam].
Sayin Kutlu S; Saçar S; Süzer T; Cevahir N; Okke D; Dirgen Caylak S; Turgut H
Mikrobiyol Bul; 2008 Apr; 42(2):353-8. PubMed ID: 18697435
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic options for Acinetobacter baumannii infections.
Vila J; Pachón J
Expert Opin Pharmacother; 2008 Mar; 9(4):587-99. PubMed ID: 18312160
[TBL] [Abstract][Full Text] [Related]
17. Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review.
Karaiskos I; Galani L; Baziaka F; Giamarellou H
Int J Antimicrob Agents; 2013 Jun; 41(6):499-508. PubMed ID: 23507414
[TBL] [Abstract][Full Text] [Related]
18. Cure of multidrug-resistant Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin.
Michalopoulos A; Kasiakou SK; Rosmarakis ES; Falagas ME
Scand J Infect Dis; 2005; 37(2):142-5. PubMed ID: 15764204
[TBL] [Abstract][Full Text] [Related]
19. Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review.
Ng J; Gosbell IB; Kelly JA; Boyle MJ; Ferguson JK
J Antimicrob Chemother; 2006 Nov; 58(5):1078-81. PubMed ID: 16916866
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis.
Jiménez-Mejías ME; Pichardo-Guerrero C; Márquez-Rivas FJ; Martín-Lozano D; Prados T; Pachón J
Eur J Clin Microbiol Infect Dis; 2002 Mar; 21(3):212-4. PubMed ID: 11957024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
